FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$237M
1-Year Est. Return
107.53%
This Fund
S&P 500
1 Year Est. Return
+107.53%
AUM
$237M
AUM Growth
+$7.37M
(+3.2%)
Holding
8
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pharvaris
PHVS
$2.17B
| $135M | 56.94% |
4,778,581
|
|
||
2
Cytokinetics
CYTK
$9.7B
| $33.2M | 13.99% |
503,295
+45,000
|
|
||
|
EIKN
3
Eikon Therapeutics
EIKN
$485M
| $20.6M | 8.67% |
+1,943,682
|
|
||
4
Lyell Immunopharma
LYEL
$279M
| $16.1M | 6.77% |
800,399
|
|
||
5
Relay Therapeutics
RLAY
$2.95B
| $9.95M | 4.2% |
1,000,000
|
|
||
6
Xenon Pharmaceuticals
XENE
$5B
| $9.3M | 3.92% |
160,000
|
|
||
7
Alector
ALEC
$182M
| $8.36M | 3.53% |
3,887,200
|
|
||
|
MAZE
8
Maze Therapeutics
MAZE
$1.34B
| $4.68M | 1.98% |
156,901
-365,756
|
|